CF
ABBV icon

Clarity Financial’s AbbVie ABBV Stock Holding History

Clarity Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50M Buy
198,762
+16,086
+9% +$3.46M 4.25% 5
2026
Q1 		$39.7M Buy
182,676
+691
+0.4% +$153K 4.32% 3
2025
Q4 		$41.6M Sell
181,985
-23,870
-12% -$5.44M 3.85% 4
2025
Q3 		$47.7M Buy
205,855
+3,372
+2% +$687K 4.73% 2
2025
Q2 		$37.6M Buy
202,483
+20,704
+11% +$3.85M 4.04% 4
2025
Q1 		$38.1M Sell
181,779
-24,593
-12% -$4.78M 4.38% 4
2024
Q4 		$36.7M Buy
206,372
+39,626
+24% +$7.29M 4.38% 4
2024
Q3 		$32.9M Buy
166,746
+12,121
+8% +$2.26M 3.82% 5
2024
Q2 		$26.5M Buy
154,625
+3,137
+2% +$520K 3.92% 5
2024
Q1 		$27.6M Sell
151,488
-15,071
-9% -$2.6M 4.17% 5
2023
Q4 		$25.8M Buy
166,559
+21,908
+15% +$3.19M 4.47% 4
2023
Q3 		$21.6M Sell
144,651
-1,253
-0.9% -$184K 3.62% 6
2023
Q2 		$19.7M Buy
145,904
+139,516
+2,184% +$20.5M 2.8% 6
2023
Q1 		$1.02M Sell
6,388
-73,967
-92% -$11.3M 3.76% 5
2022
Q4 		$13M Buy
80,355
+3,979
+5% +$610K 2.51% 6
2022
Q3 		$10.3M Sell
76,376
-20,694
-21% -$2.97M 2.4% 9
2022
Q2 		$14.9M Buy
97,070
+7,824
+9% +$1.2M 3.22% 6
2022
Q1 		$14.5M Sell
89,246
-16,912
-16% -$2.46M 2.93% 6
2021
Q4 		$14.4M Sell
106,158
-6,855
-6% -$810K 2.24% 9
2021
Q3 		$12.2M Buy
113,013
+36,284
+47% +$4.15M 1.98% 10
2021
Q2 		$8.64M Buy
76,729
+32,436
+73% +$3.65M 1.66% 15
2021
Q1 		$4.79M Buy
44,293
+15,496
+54% +$1.66M 0.97% 24
2020
Q4 		$3.09M Buy
+28,797
New +$2.77M 0.74% 38

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Clarity Financial's ABBV Position: Q2 2026 in Review

Clarity Financial increased its AbbVie (ABBV) stake by 8.8% in Q2 2026, buying an estimated $3.46M and bringing the position to 198,762 shares worth $50M. The position accounts for 4.25% of the portfolio, ranked #5.

Clarity Financial first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarity Financial held 198,762 shares of AbbVie worth $50M as of Q2 2026.
  • Clarity Financial bought 16,086 AbbVie shares in Q2 2026, an estimated $3.46M.
  • AbbVie made up 4.25% of Clarity Financial's portfolio in Q2 2026, its #5 holding.
  • Clarity Financial first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarity Financial's 13F filing for Q2 2026, filed 20 Jul 2026.